emboli
[용어속성] Term
Multiple simultaneous embolic cerebral infarctions 11 months after COVID-19
Case Report
[키워드] anticoagulation
Case report
Coagulopathy
consequence
coronavirus disease
COVID-19
COVID-19 diagnosis
COVID-19 illness
D-dimer
disease
elevated
emboli
embolic
etiology
General population
highlight
implication
Infarction
initial
Mild
Multiple
pandemic
paradoxical
Patient
prevalent
Pulmonary emboli
Pulmonary embolus
serious complication
Shortness of breath
stroke
the patient
Thromboembolic event
Thrombolysis
treated
Venous Thromboembolism
VTE
was determined
[DOI] 10.1186/s12959-021-00304-8 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1186/s12959-021-00304-8 PMC 바로가기 [Article Type] Case Report
Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability
Internal Medicine
[키워드] Abnormalities
Acute limb ischemia
acute respiratory distress
acute respiratory syndrome
anticoagulation
aorta thrombosis
Aortic thrombosis
ARDS
Arterial thrombosis
arterial thrombus occlusion
Autoimmune
blood flow
coronavirus
coronavirus disease
COVID
COVID 19
covid hypercoagulability
COVID-19
covid-related hypercoagulability
descending
diaphragmatic
disorder
Echocardiogram
emboli
Evidence
highlight
hypercoagulable
Inflammatory
initial
Intervention
intraventricular
Ischemia
limb
male
management
manifestation
moderate
pandemic
Pneumonia
Prophylactic
prothrombotic
public health emergency
pulmonary disease
pulmonary hypertension
randomized control trial
reported
required
SARS-CoV-2
secondary to
septal
severe adverse effect
Spread
surgical
syndrome
the patient
therapeutic
thromboembolic risk
thrombosis
Vasculitis
Venous thrombosis
ventricular
while
Wuhan, China
[DOI] 10.7759/cureus.16171 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.16171 PMC 바로가기 [Article Type] Internal Medicine
Widespread Parenchymal Abnormalities and Pulmonary Embolism on Contrast-Enhanced CT Predict Disease Severity and Mortality in Hospitalized COVID-19 Patients
Medicine
[키워드] affecting
Analysis
Anticoagulant treatment
approach
Better
C-reactive protein
Characteristics
Clinical deterioration
clinical suspicion
cohort analysis
collected
Computed tomography
confidence interval
contributed
correlated
COVID-19
COVID-19 patient
creatinine
Critical care
CTPA
D-dimer
emboli
Embolism
examined
Factor
hemoglobin
high mortality
highest
Hospitalized
ICU
IMPROVE
Inflammation
interquartile range
intravenous
Laboratory parameters
lesion
liberal
main pulmonary artery
median age
men
Mortality
mortality data
mortality risk
MOST
outcome
parenchymal
parenchymal abnormalities
parenchymal abnormality
Patient
patients
PCR-positive patient
plasma
predict
procalcitonin
pulmonary
Pulmonary embolism
pulmonary infiltrates
Pulmonary thromboembolism
pulmonary trunk
radiological
radiologist
retrospective
severe systemic disease
severity
significantly
single-center
stratified
thromboembolic disease
tomography
Troponin-T
were recorded
widespread
women
[DOI] 10.3389/fmed.2021.666723 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.666723 PMC 바로가기 [Article Type] Medicine
COVID-19 Viral Pneumonia Complicated with Acute Pulmonary Embolism: A Descriptive Study
Research Article
[키워드] 2019 novel coronavirus
acute pulmonary embolism
age
analyzed
approved
common
consolidation
cough
COVID-19
CT findings
CT sign
D-dimer level
Deterioration
diagnosed
disease
distribution
elevated
emboli
evaluate
Evidence
fatigue
female
Fever
GGO
ground-glass opacity
headache
hospital
identify
institutional review board
less
lobar
Lung disease
maintain
male
objective
parenchymal
Patient
performed
Pneumonia
pulmonary
pulmonary artery
pulmonary CT
Pulmonary embolism
Result
right lower lobe
RT-PCR
Saudi Arabia
serum
Shortness of breath
sore throat
subsegmental
Symptom
symptom onset
symptomatic patient
the patient
thromboembolic complication
Unilateral
was done
were recorded
with COVID-19
[DOI] 10.1155/2021/6649086 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2021/6649086 PMC 바로가기 [Article Type] Research Article
Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials
Research article
[키워드] activate
acute respiratory distress syndrome
Alpha
alveolar
Anti-inflammatory therapy
Anti-viral
anti-viral effect
anticoagulant therapy
anticoagulation
approach
ARDS
ARDSacute respiratory distress syndrome
Bacterial
Beta
Blood
C-reactive protein
Care
Cell
chemokines
clinical outcomes
clinically
Coagulopathy
Comorbidities
Computerized tomography
concerning
Coronaviruses
COVID-19
COVID-19 infection
CoVscoronaviruses
criteria
CRPC-reactive protein
CTcomputerized tomography
CXCL10chemokines
CXCL9
cytokine
D-dimer
diagnose
Diagnosis
diagnostic
DICdisseminated intravascular coagulation
Digital
Disseminated intravascular coagulation
distress
effective
elevated
emboli
extreme
General population
GGOground glass opacities
gluthathione
ground glass opacities
GSHgluthathione
Health
Health authority
healthy
help
high mortality rate
highest
hypothetical
ICUIntensive Care Unit
identify
IL-10interleukin 10
IL-12interleukin 12
IL-18interleukin 18
IL-1βinterleukin 1 beta
IL-33interleukin 33
IL-6interleukin 6
IL-7Interleukin 7
IL-8interleukin 8
immune
immune function
immunomodulatory
implementation
increase in
individual
individuals
Inflammation
intensive care unit
interleukin 1 beta
Interleukin 10
interleukin 12
interleukin 18
interleukin 33
interleukin 6
Interleukin 7
interleukin 8
Intervention
Isolation
Ivermectin
lactic dehydrogenase
LDHlactic dehydrogenase
LDLyme disease
literature review
Lyme disease
macrophage activation syndrome
MASmacrophage activation syndrome
MERS coronavirus
MERS-CovMERS coronavirus
morbidity and mortality
Multiorgan dysfunction
N-acetyl-cysteine
NACN-acetyl-cysteine
NCPnovel coronavirus pneumonia
New
NF-κB
novel coronavirus pneumonia
NSnutritional support
nutraceutical
nutritional support
organ
outcomes
oxygen
Oxygenation
pandemic
Pathways
Patient
performed
physical distancing
Pneumonia
precursor
Prevent
protocol
questionnaire
Randomized controlled trial
randomized trial
randomized, controlled trials
required
resource
respiratory therapy
resulting
risk
SARS-CoV-2severe acute respiratory syndrome coronavirus 2
scored
screening questionnaire
second
Sepsis
serum
severe acute respiratory syndrome coronavirus 2
severe complication
silent
statistical
statistically
Stress
sulforaphane
Support
Symptom
symptomatic infection
TGFβtransforming growth factor beta
the disease
therapy
thrombotic event
TNF-αtumor necrosis factor alpha
transforming growth factor beta
Transmission
Treatment
Treatment strategies
tumor necrosis factor alpha
ventilator
vital sign
Vitamin C
WHOWorld Health Organization
with COVID-19
World Health Organization
[DOI] 10.1016/j.mehy.2020.109851 [Article Type] Research article
[DOI] 10.1016/j.mehy.2020.109851 [Article Type] Research article
Etiologic Subtypes of Ischemic Stroke in SARS-CoV-2 Patients in a Cohort of New York City Hospitals
Neurology
[키워드] acute ischemic strokes
acute phase
African American
age
Atherosclerosis
Atrial fibrillation
Characteristics
Cohort
collected
coronary disease
coronavirus disease
COVID-19
CRP
D-dimer level
demographics
diabete
elevated
emboli
emergent large vessel occlusion
etiology
event
female
group
hospital
hypertension
inflammatory markers
investigated
Ischemic
Ischemic Stroke
Laboratory
large vessel
male
marker
Mechanical thrombectomy
median age
Mortality
MOST
neurological manifestation
New York City
outcome
pathophysiology
Patient
patients
procalcitonin
ranged
reported
Risk factors
SARS-CoV-2
severity
significantly higher
small vessel
South Asian
stroke
subtype
syndrome
Vascular
[DOI] 10.3389/fneur.2020.01004 PMC 바로가기 [Article Type] Neurology
[DOI] 10.3389/fneur.2020.01004 PMC 바로가기 [Article Type] Neurology
Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective study
COVID-19 폐렴 및 높은 D-dimer 값을 가진 환자에서 폐색전증의 유병률: 전향적 연구
Research Article
[키워드] abnormal coagulation
Administered
analysed
anticoagulant therapy
C reactive protein
C reactive protein values
Clinical outcome
clinical outcomes
clinical suspicion
clinically suspected
Coagulation
Comorbidities
Computed tomography
Computed tomography pulmonary angiography
confirmed case
consecutive patient
contribute
coronavirus disease
Coronavirus disease 2019
correlated
COVID-19
COVID-19 pneumonia
CTPA
D-dimer
D-dimer elevation
D-dimer value
D-dimer values
demographic
diagnose
diagnosed
diagnoses
disease severity
emboli
IMPROVE
in-hospital mortality
IQR
laboratory data
magnitude
material
median age
non-PE
non-PE group
not differ
Older
Patient
patients with COVID-19
patients with PE
PE patients
Platelet
Platelet count
Pneumonia
Prevalence
Prognosis
prognosis of patient
prospective cohort study
Prospective Study
pulmonary angiography
Pulmonary embolism
radiologic magnitude
Result
Retrospective study
risk factor
segmental arteries
segmental artery
Sex
significantly
significantly higher
systemic hyper-inflammation
thromboembolic
thromboembolic disease
with COVID-19
women
[DOI] 10.1371/journal.pone.0238216 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0238216 PMC 바로가기 [Article Type] Research Article